A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types
Clinical trial NCT02296879 · COMPLETED
Trial details
- NCT number
- NCT02296879
- Sponsor
- Young Suk Park
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-20
- Primary completion
- 2017-03-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.